BUY Divi's Laboratories Limited — Akshay Bhagwat, JM Financial
byAkshay Bhagwat, JM FinancialHorizon: Swing (≤2wk)22 Jul 2026via Business Today
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%
NewsGoogle News·27 Jul · yesterday
Divi's Laboratories begins commercial operations at Unit III greenfield project in Kakinada
NewsGoogle News·25 Jul · 3d ago
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·21 Jul · 1w ago
1500% Dividend Bonanza! Pharma Stock In Spotlight After Mega Payout; Record Date Announced
NewsGoogle News·14 Jul · 2w ago
Divi's Laboratories Recommends ₹30 Final Dividend for FY26
NewsGoogle News·13 Jul · 2w ago
Divis Labs: ₹30 டிவிடெண்ட்! இந்த தேதியை தவறவிடாதீர்கள்!
NewsGoogle News·23 Jul · 5d ago
Divis Labs Ex-Dividend Date July 24: What Investors Should Know
NewsGoogle News·23 Jul · 5d ago
Divis Labs Share Price: રોકાણકારો માટે મહત્વના સમાચાર! ₹30 ડિવિડન્ડ માટે Ex-Dividend Date જાહેર
NewsGoogle News·23 Jul · 5d ago
Divis Laboratories reduces carbon footprint in FY 2025-26
NewsGoogle News·15 Jul · 2w ago
Divis Laboratories fixes July 24 record date for ₹30 dividend
NewsGoogle News·15 Jul · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

